Johnson & Johnson
Johnson & Johnson is reducing its 4,820 employees worldwide, as it’s facing stiff pressure for patent expirations on two important drugs over the next two years, which can erode profits worth million dollars.
The cut would amount 3 to 4 % of the...
Related Stories
Most Recent
Most Popular
Most Commented
Quitting smoking, losing weight, and renouncing alcohol and cocaine may lead you to the risk of depression and even the chances of suicide. Now, it’s so very evident...
made popular Apr 28 2008
Pfizer Inc., the New York Company got the green signal from the FDA in promoting Celebrex painkiller for treating children with a distressing form of arthritis.
The...
made popular Dec 17 2006
Pfizer Inc. is planning to get approval for a new pill to treat heart problems. The pill, torcetrapib in the combination with Lipitor, treats cholesterol problems.
The...
made popular Jul 27 2006
Johnson & Johnson, made the victory over Pfizer Inc.’s consumer health care unit for a price of $16.6 billion.
Bill Weldon, J&J’s CEO, says The...
made popular Jul 1 2006
Lipitor, a medicine by Pfizer Inc., is used to reduce the risk of heart attacks and strokes. However, a new research has found that these types of cholesterol reducing...
made popular Jul 1 2006
Twenty-five percent of all diabetics suffer from depression. According to a U.S. study, Zoloft, an anti-depressant may reduce the chronic depression in diabetics. It is...
made popular May 6 2006
Pfizer Inc., the leader in pharmaceutical industry and also the maker of Listerine mouthwash this Friday sued Procter & Gamble Co. because it was falsely claiming...
made popular Mar 4 2006
Elusive genetic variations that make people vulnerable to some of the most common diseases need to be uncovered, and on this line Government scientists are launching a...
made popular Feb 10 2006
All Stories
Most Recent
Most Popular
Most Commented
Health-care products maker Johnson & Johnson won U.S. approval to sell a new HIV drug called Intelence for patients with resistance to other therapies, U.S....
made popular Jan 19 2008
A Johnson & Johnson, the U.S. farm, executive has stepped down as alleged to involve in the embezzlement and suspect to made improper payment of its medical...
made popular Feb 13 2007
Johnson & Johnson, made the victory over Pfizer Inc.’s consumer health care unit for a price of $16.6 billion.
Bill Weldon, J&J’s CEO, says The...
made popular Jul 1 2006
People are tired of watching 30 second television adverts on video formats. It seems. So, going by the demand of the market, Chief executive of Metacafe, a video...
made popular Apr 26 2006
Systems integrator Integral RFID has announced the release of version 2.0 of its Instant EPC Hotspot software. Integral introduced it about a year back to enable end...
made popular Mar 20 2006
Guidant, the embattled medical device maker, said Monday that it was suing its reluctant acquirer Johnson & Johnson, signaling that negotiations between the...
made popular Nov 7 2005
Related Tags
Bart Stupak Business EPC UHF Class 1 Gen 2 FDA Guidant Health & Fitness heavy.com iFilm Instant EPC V2.0 Integral RFID Medical Cognition Laboratory Merck & Co Inc Nasonex Nestle Pfizer Inc. pharmaceutical companies Ruth Day Technology U.S. United States
Home

RSS



















